02/21/2025 5:11 AM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025 4:06 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025 3:56 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025 10:54 AM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025 3:15 PM | Ascendis Pharma A/S (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
02/12/2025 2:24 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2025 8:15 AM | Ascendis Pharma A/S (Subject) WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SCHEDULE 13G/A | |
01/15/2025 3:39 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 5:03 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 5:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024 3:04 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for ASND and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.
|
12/17/2024 5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024 4:02 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 4:07 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 4:16 PM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 3:44 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 3:35 PM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 4:46 PM | Ascendis Pharma A/S (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024 1:57 PM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024 8:31 AM | Ascendis Pharma A/S (Subject) Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/13/2024 3:02 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 8:51 AM | Artisan Partners Limited Partnership (Filed by) Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
11/08/2024 9:34 AM | Ascendis Pharma A/S (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/04/2024 6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 7:35 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024 3:59 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 4:20 PM | Ascendis Pharma A/S (Filer)
| Form 424B5 | |
09/18/2024 3:01 PM | Ascendis Pharma A/S (Filer)
| Form F-3ASR | |
09/16/2024 6:28 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 6:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024 3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:14 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024 6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024 5:07 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 3:26 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 3:08 PM | Ascendis Pharma A/S (Filer)
| Form SD Specialized Disclosure Report | |
05/14/2024 1:37 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024 8:16 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2024 10:31 AM | Ascendis Pharma A/S (Subject) Bodenhoff Mads (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
The FED is losing the war on inflation (Ad) It's no longer just a “guesstimate” – Inflation is indeed getting worse.
And although we want to believe the Fed has a good grip on it, they don't.
Right now, the suits over there are caught between a rock and a hard place.
Either they watch as inflation grows, or they tear it down and send us into a full-blown recession.
The kicker here is that neither of these are good for you.
Whichever pill we end up with, prices will still climb higher as the value of the dollar sinks lower.
The only real way out for the regular person is to increase your earning power.
By increasing your income to match prices as they flare up…
You’ll stay ahead of the impending doom we're running face-first into.
And if you're looking for a strategy to help increase your income in 2025…
I've got just the thing for you!
You see, last year, I was able to grow a $10k model account to a little over $63k with 100 trade alerts
But I changed my trading rules and more than doubled my results on those 100 published trades.
I'm now calling them Warped Options… You can go here to give yourself a head start. |
03/05/2024 8:39 PM | Ascendis Pharma A/S (Subject) Fairey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 8:47 AM | Ascendis Pharma A/S (Subject) Cha Albert (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 7:04 AM | Ascendis Pharma A/S (Subject) SPROGOE KENNETT (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 7:14 AM | Ascendis Pharma A/S (Subject) Morrison Lisa (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:52 AM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024 6:37 AM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 1:54 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 2:07 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 2:17 PM | Ascendis Pharma A/S (Subject) RASMUSSEN PETER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 1:36 PM | Ascendis Pharma A/S (Subject) SMITH SCOTT THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 1:24 PM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 10:00 AM | Ascendis Pharma A/S (Subject) HOLTUG LARS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:13 PM | Ascendis Pharma A/S (Subject) Morrison Lisa (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 3:21 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024 5:17 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 4:45 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |